Skip to main content

Table 1 Cytogenetic band(s) where RER regions common to breast tumors and breast cancer cell lines are located

From: Estrogen-induced chromatin decondensation and nuclear re-organization linked to regional epigenetic regulation in breast cancer

Cytogenetic location

Size (Mb)

Number of significant TCSs (tumor/cell line)

Number of other significantly correlated genes (tumor/cell line)

Genes in RER regions with significant TCSs

Gene expression (tumor versus normal)

6p22.2

0.89

3/34

14/28

C6orf62, GMNN, HIST1H4C/Histone gene cluster, ZSCAN16, GPX5, OR2W1, OR2J3, OR2N1P, OR12D2, OR10C1, MOG

Up

6q23.2-q23.3

3.43

12/3

26/10

TAAR5, TAAR3, VNN3, IFNGR1, HEBP2, ABRACL, HECA, VTA1, PEX3, FUCA2, LTV1, SHPRH, PPIL4, RMND1, C6orf211

Down

6q25.1-q25.3

6.71

12/3

26/7

RP23-468K3.1, RP3-527B10.1, OPRM1

Down

8p11.21-q11.23

13.41

6/6

17/8

TM2D2, GOLGA7, KAT6A, AP3M2, IKBKB, POLB, VDAC3, SLC20A2, SMIM19, MCM4, MRPL15

Down

8q21.13-q21.3

10.54

32/6

33/11

NBN, OTUD6B, RAD54B, KIAA1429, ESRP1, INTS8, PLEKHF2, MTERFD1, PTDSS1, MTDH, HRSP12, AP003355.2, VPS13B, ANKRD46, UBR5, AZIN1, ATP6V1C1, SLC25A32, TTC35, TAF2, MRPL13, DERL1, ATAD2, WDYHV1, TRMT12, RNF139/KCNB2, STAU2, FAM164A, STMN2, FAM82B, MMP16

No change

8q22.1-q23.1

11.99

32/11

33/3

NBN, OTUD6B, RAD54B, KIAA1429, ESRP1, INTS8, PLEKHF2, MTERFD1, PTDSS1, MTDH, RPL30, HRSP12, AP003355.2, NIPAL2, VPS13B, COX6C, SPAG1, RNF19A, ANKRD46, UBR5, AZIN1, ATP6V1C1, FZD6, SLC25A32, EMC2, TAF2, MRPL13, DERL1, ATAD2, WDYHV1, TRMT12, RNF139

No change

9p13.3

1.13

2/6

20/11

NOL6, SIGMAR1, KIAA1045, DNAJB5, RUSC2, CD72, SIT1, CA9

No change

10p13-p12.31

6.71

5/3

22/10

UPF2, CDC123, HSPA14, RPP38, NMT2, RSU1, STAM

Down

10q26.11-q26.13

6.34

3/5

21/10

BAG3, C10orf119, SEC23IP, BRWD2, PLEKHA1, IKZF5

No change

11q12.3-q13.1

0.75

5/2

27/9

C11orf48, WDR74, COX8A, OTUB1, MACROD1, NUDT22, RPS6KA4

Up

11q13.2

0.36

6/2

18/9

KAT5, FIBP, CCDC85B, SART1, SF3B2, YIF1A , SPTBN2, C11orf80

Up

12q21.31-q21.33

10.39

2/4

17/12

RAB21, PPP1R12A , NTS, MGAT4C, DCN, EEA1

Down

16p13.3

2.16

23/23

33/22

AXIN1, TMEM8A, NME4, RAB11FIP3, PIGQ, RAB40C, LA16c-398G5.2, WDR90, RHOT2, WDR24, METRN, FAM173A, CCDC78, NARFL, IFT140, NME3, MRPS34, HAGH, NDUFB10, GFER, NTHL1, TRAF7, MLST8, E4F1, GNG13, LMF1, CACNA1H, TPSG1, TPSD1, UBE2I, BAIAP3, PGP

Up

16p13.3

1.45

4/5

16/12

OR1F1, OR2C1, NAA60, ADCY9, TFAP4, DNAJA3, ANKS3, ROGDI, UBN1

Up

16p12.3

0.38

3/2

13/6

KNOP1, GP2, EARS2, NDUFAB1, PALB2

No change

16p11.2

1.36

6/25

22/13

SEZ6L2, TAOK2, HIRIP3, DOC2A, ALDOA, PPP4C, TBX6, MAPK3, CD2BP2, TBC1D10B, ZNF48, ZNF771, ZNF768, ZNF747, ZNF764, ZNF688, ZNF785, PRR14, FBRS, SRCAP, PHKG2, RNF40, ZNF629, BCL7C, CTF1, SETD1A, VKORC1

Up

16q22.1-q22.2

4.9

22/11

71/17

CDH16, NOL3, E2F4, ATP6V0D1, THAP11, PSKH1, DDX28, DUS2L, PRMT7, COG4, VAC14

Down

17p11.2

1.69

17/3

26/6

TOM1L2, LRRC48, LLGL1

Down

17q11.2

0.53

17/4

26/6

UNC119, KIAA0100, SDF2, SUPT6H

Up

17q21.2

0.28

17/6

13/9

KRTAP1-3, KRTAP1-1, KRTAP2-4, KRTAP4-9, KRT34, KRT31

No change

17q25.1

0.9

24/4

20/6

KCTD2, GGA3, MRPS7, GRB2

Up

17q25.3

0.58

13/4

18/13

STRA13, RFNG, CSNK1D, SECTM1

Up

22q11.23-q12.1

5.93

5/13

15/20

TRMT2A, P2RX6, TOP3B, PPIL2, IGLV1-40, ZNF280B, ZNF280A, ZDHHC8P, VPREB3, MMP11, UPB1, SEZ6L, CRYBB1

Down

22q12.2-q12.3

1.01

3/2

15/11

INPP5J, PIK3IP1

No change

22q12.3

0.24

3/4

15/12

TMPRSS6, SSTR3, MFNG, GCAT

No change

22q13.1-q13.2

1.37

2/6

16/10

CBX6, APOBEC3A, PDGFB, MGAT3, CACNA1I, SGSM3

No change

  1. The RER region size (measured as the first to last significant TCS in the region), the number of genes with significant TCSs in the tumor or cell line data, the number of other genes in the region which have significantly correlated expression with the TCS genes (again for tumors and cell lines), and the list of those genes with significant TCSs. The gene expression of the region in tumors compared with normal samples is also indicated